In one paragraphArticle in Organic letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 5 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors at 3 institutions in 3 countries.
Xhenti FerhatiDepartamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja, 26006 Logroño, La Rioja, Spain.
Marina Salas-CuberoDepartamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja, 26006 Logroño, La Rioja, Spain.
Pablo GarridoAngiogenesis Group, Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), 26006 Logroño, Spain.ORCID 0000-0002-5960-8569 Josune García-SanmartínAngiogenesis Group, Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), 26006 Logroño, Spain.ORCID 0000-0003-4391-5537 Ana GuerreiroInstituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina de Universidad de Lisboa, 1649-028 Lisboa, Portugal.
Alberto AvenozaDepartamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja, 26006 Logroño, La Rioja, Spain.
Jesús H BustoDepartamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja, 26006 Logroño, La Rioja, Spain.ORCID 0000-0003-4403-4790 Jesús M PeregrinaDepartamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja, 26006 Logroño, La Rioja, Spain.ORCID 0000-0003-3778-7065 Alfredo MartínezAngiogenesis Group, Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), 26006 Logroño, Spain.ORCID 0000-0003-4882-4044 Ester Jiménez-MorenoDepartamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja, 26006 Logroño, La Rioja, Spain.ORCID 0000-0002-5045-433X Gonçalo J L BernardesInstituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina de Universidad de Lisboa, 1649-028 Lisboa, Portugal.ORCID 0000-0001-6594-8917 Francisco CorzanaDepartamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja, 26006 Logroño, La Rioja, Spain.ORCID 0000-0001-5597-8127 Universidad de La Rioja · ESCenter for Biomedical Research of La Rioja · ESUniversity of Lisbon · PT
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
A self-immolative bioorthogonal conditionally cleavable linker based on Grob fragmentation is described. It is derived from 1,3-aminocyclohexanols and allows the release of sulfonate-containing compounds in aqueous media. Modulation of the amine p
Identifiers
PMID34694118
PMCPMC8576835
OpenAlexW3210823435
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390